Lamivudine-based two-drug regimens with dolutegravir or protease inhibitor: Virological suppression in spite of previous therapy failure or renal dysfunction Elaine Monteiro Matsuda; Ivana Barros Campos; Isabela Penteriche de Oliveira; Daniela Rodrigues Colpas; Giselle Ibete Silva López-Lopes; Victor Oliveira Chiavegato; Luís Fernando de Macedo Brígido;